↓ Skip to main content

ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, April 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)

Mentioned by

twitter
13 tweeters

Citations

dimensions_citation
119 Dimensions

Readers on

mendeley
90 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway
Published in
Journal of Experimental & Clinical Cancer Research, April 2019
DOI 10.1186/s13046-019-1156-5
Pubmed ID
Authors

Qi Zhang, Sihong Lu, Tianfu Li, Liang Yu, Yunjian Zhang, Huijuan Zeng, Xueke Qian, Jiong Bi, Ying Lin

Twitter Demographics

The data shown below were collected from the profiles of 13 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 90 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 90 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 17%
Student > Bachelor 14 16%
Student > Ph. D. Student 8 9%
Student > Master 6 7%
Student > Doctoral Student 4 4%
Other 6 7%
Unknown 37 41%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 20 22%
Medicine and Dentistry 17 19%
Immunology and Microbiology 5 6%
Engineering 2 2%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Other 5 6%
Unknown 39 43%

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 August 2022.
All research outputs
#2,783,792
of 21,973,852 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#103
of 1,958 outputs
Outputs of similar age
#60,628
of 297,760 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#1
of 1 outputs
Altmetric has tracked 21,973,852 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,958 research outputs from this source. They receive a mean Attention Score of 3.7. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 297,760 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them